期刊文献+

多重耐药鲍曼不动杆菌的分子流行病学及耐药机制研究 被引量:16

原文传递
导出
摘要 近年来,随着广谱抗菌药物的广泛应用,多重耐药鲍曼不动杆菌(multi-drug resistant Acinetobacter baumannii,MDRAB)的分离率日益增加。该菌在干燥物体表面生存时间可长达25d以上,极易造成医院内播散流行。
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2011年第4期343-344,共2页 Chinese Journal of Microbiology and Immunology
  • 相关文献

参考文献6

  • 1Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev, 2008, 21(3): 538-582.
  • 2Adams-Haduch JM, Paterson DL, Sidjabat HE, et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicreb Agents Chemother , 2008, 52( 1 ) : 3837-3843.
  • 3朱冰泉,沈萍,俞云松,张幸国.对亚胺培南耐药的鲍曼不动杆菌同源性及碳青霉烯酶基因型研究[J].浙江医学,2008,30(5):459-462. 被引量:25
  • 4Fu Y, Zhou J, Zhou H, et al. Wide dissemination of OXA-23- producing carbapenem-resistant Acinetobacter baumannii clonat complex 22 in multiple cities of China. J Antimicrob Chemother, 2010, 65(4) : 644-650.
  • 5Wang H, Guo P, Sun H, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother, 2007, 51 ( 11 ) : 4022-4028.
  • 6Yu YS, Zhou H, Yang Q, et al. Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China. J Antimicrob Chemoth- er, 2007, 60(2) : 454-455.

二级参考文献12

  • 1Lenie D, Alexandr N, Harald S. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii [J]. Nature Reviews Microbiology, 2007, 5(12): 939-951.
  • 2Simor A E, Bradley S F, Strausbaugh L J, et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management [J]. Infect Control Hosp Epidemiol, 2002, 23(5): 261-267.
  • 3Byung-Chan Jeon, Seok Hoon Jeong, Kwon Bae, et al. Investigation of a nosocomial outbreak of imipenem-resistant acine - tobacter baumannii producing the OXA-23 β-Iactamase in Korea [J]. J Clin Microbiol, 2005, 43(5): 2241-2245.
  • 4Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil [J]. J Clin Microbiol, 2003, 41 (7):3403-3406.
  • 5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement[J]. Clinical and Laboratory Standards Institute, 2006 26: M100-S16.
  • 6Tenover F C, Arbeit R D, Goering R V, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis criteria for bacterial strain typing [J]. J Clin Microbiol, 1995, 33(9): 2233-2239.
  • 7Jane F T, M. Elaina Ward, Neil Woodford, et al. The role of ISAbal in expression of OXA carbapenemase genes in Acinetobacter baumannii[J]. FEMS Microbiol Lett, 2006, 258(1): 72-77.
  • 8Joly-Guillou M L. Clinical impact and pathogenicity of Acinetobacter [J]. Clin Microbiol Infect, 2005, 11(11): 868-873.
  • 9Tatman-Otkun M, Gurcan S, Ozer B,et al. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations [J]. New Microbiol, 2004, 27(1 ):21-28.
  • 10Jan Walther-Rasmussen, Niels Hoiby.OXA-type carbapenemases [J]. J Antimicrob Chemother, 2006, 57(3): 373-383.

共引文献24

同被引文献146

引证文献16

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部